-
1
-
-
84937604711
-
Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment
-
Alexandrova EM, Yallowitz AR, Li D, Xu S, Schulz R, Proia DA, Lozano G, Dobbelstein M, Moll UM. 2015. Improving survival by exploiting tumour dependence on stabilized mutant p53 for treatment. Nature 523: 352-356
-
(2015)
Nature
, vol.523
, pp. 352-356
-
-
Alexandrova, E.M.1
Yallowitz, A.R.2
Li, D.3
Xu, S.4
Schulz, R.5
Proia, D.A.6
Lozano, G.7
Dobbelstein, M.8
Moll, U.M.9
-
2
-
-
0345268720
-
Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis
-
Alt JR, Greiner TC, Cleveland JL, Eischen CM. 2003. Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis. EMBO J 22: 1442-1450
-
(2003)
EMBO J
, vol.22
, pp. 1442-1450
-
-
Alt, J.R.1
Greiner, T.C.2
Cleveland, J.L.3
Eischen, C.M.4
-
4
-
-
0024536654
-
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas
-
Baker SJ, Fearon ER, Nigro JM, Hamilton SR, Preisinger AC, Jessup JM, van Tuinen P, Ledbetter DH, Barker DF, Nakamura Y, et al. 1989. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244: 217-221
-
(1989)
Science
, vol.244
, pp. 217-221
-
-
Baker, S.J.1
Fearon, E.R.2
Nigro, J.M.3
Hamilton, S.R.4
Preisinger, A.C.5
Jessup, J.M.6
van Tuinen, P.7
Ledbetter, D.H.8
Barker, D.F.9
Nakamura, Y.10
-
5
-
-
84899622427
-
Unravelling mechanisms of p53-mediated tumour suppression
-
Bieging KT, Mello SS, Attardi LD. 2014. Unravelling mechanisms of p53-mediated tumour suppression. Nat Rev Cancer 14: 359-370
-
(2014)
Nat Rev Cancer
, vol.14
, pp. 359-370
-
-
Bieging, K.T.1
Mello, S.S.2
Attardi, L.D.3
-
6
-
-
8844278362
-
A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans
-
Bond GL, Hu W, Bond EE, Robins H, Lutzker SG, Arva NC, Bargonetti J, Bartel F, Taubert H, Wuerl P, et al. 2004. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119: 591-602
-
(2004)
Cell
, vol.119
, pp. 591-602
-
-
Bond, G.L.1
Hu, W.2
Bond, E.E.3
Robins, H.4
Lutzker, S.G.5
Arva, N.C.6
Bargonetti, J.7
Bartel, F.8
Taubert, H.9
Wuerl, P.10
-
7
-
-
70349443284
-
When mutants gain new powers: News from the mutant p53 field
-
Brosh R, Rotter V. 2009. When mutants gain new powers: News from the mutant p53 field. Nat Rev Cancer 9: 701-713
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 701-713
-
-
Brosh, R.1
Rotter, V.2
-
9
-
-
84975717995
-
The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain
-
D'Abramo M, Besker N, Desideri A, Levine AJ, Melino G, Chillemi G. 2016. The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain. Oncogene 35: 3272-3281
-
(2016)
Oncogene
, vol.35
, pp. 3272-3281
-
-
D'Abramo, M.1
Besker, N.2
Desideri, A.3
Levine, A.J.4
Melino, G.5
Chillemi, G.6
-
10
-
-
70350567735
-
20 years studying p53 functions in genetically engineered mice
-
Donehower LA, Lozano G. 2009. 20 years studying p53 functions in genetically engineered mice. Nat Rev Cancer 9: 831-841
-
(2009)
Nat Rev Cancer
, vol.9
, pp. 831-841
-
-
Donehower, L.A.1
Lozano, G.2
-
11
-
-
0026561121
-
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
-
Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, Bradley A. 1992. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221
-
(1992)
Nature
, vol.356
, pp. 215-221
-
-
Donehower, L.A.1
Harvey, M.2
Slagle, B.L.3
McArthur, M.J.4
Montgomery, C.A.5
Butel, J.S.6
Bradley, A.7
-
12
-
-
0026849821
-
Definition of a consensus binding site for p53
-
El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B. 1992. Definition of a consensus binding site for p53. Nat Genet 1: 45-49
-
(1992)
Nat Genet
, vol.1
, pp. 45-49
-
-
El-Deiry, W.S.1
Kern, S.E.2
Pietenpol, J.A.3
Kinzler, K.W.4
Vogelstein, B.5
-
13
-
-
0025312728
-
A genetic model for colorectal tumorigenesis
-
Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61: 759-767
-
(1990)
Cell
, vol.61
, pp. 759-767
-
-
Fearon, E.R.1
Vogelstein, B.2
-
14
-
-
0024382760
-
The p53 proto-oncogene can act as a suppressor of transformation
-
Finlay CA, Hinds PW, Levine AJ. 1989. The p53 proto-oncogene can act as a suppressor of transformation. Cell 57: 1083-1093
-
(1989)
Cell
, vol.57
, pp. 1083-1093
-
-
Finlay, C.A.1
Hinds, P.W.2
Levine, A.J.3
-
15
-
-
33644778697
-
Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo
-
Francoz S, Froment P, Bogaerts S, De Clercq S, Maetens M, Doumont G, Bellefroid E, Marine JC. 2006. Mdm4 and Mdm2 cooperate to inhibit p53 activity in proliferating and quiescent cells in vivo. Proc Natl Acad Sci 103: 3232-3237
-
(2006)
Proc Natl Acad Sci
, vol.103
, pp. 3232-3237
-
-
Francoz, S.1
Froment, P.2
Bogaerts, S.3
De Clercq, S.4
Maetens, M.5
Doumont, G.6
Bellefroid, E.7
Marine, J.C.8
-
16
-
-
84862636275
-
Mutant p53: One name, many proteins
-
Freed-PastorWA, Prives C. 2012. Mutant p53: One name, many proteins. Genes Dev 26: 1268-1286
-
(2012)
Genes Dev
, vol.26
, pp. 1268-1286
-
-
Freed-Pastor, W.A.1
Prives, C.2
-
18
-
-
0037173059
-
The p53MH algorithm and its application in detecting p53-responsive genes
-
Hoh J, Jin S, Parrado T, Edington J, Levine AJ, Ott J. 2002. The p53MH algorithm and its application in detecting p53-responsive genes. Proc Natl Acad Sci 99: 8467-8472
-
(2002)
Proc Natl Acad Sci
, vol.99
, pp. 8467-8472
-
-
Hoh, J.1
Jin, S.2
Parrado, T.3
Edington, J.4
Levine, A.J.5
Ott, J.6
-
19
-
-
79961076734
-
The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo
-
Huang L, Yan Z, Liao X, Li Y, Yang J,Wang ZG, Zuo Y, Kawai H, Shadfan M, Ganapathy S, et al. 2011. The p53 inhibitors MDM2/MDMX complex is required for control of p53 activity in vivo. Proc Natl Acad Sci 108: 12001-12006
-
(2011)
Proc Natl Acad Sci
, vol.108
, pp. 12001-12006
-
-
Huang, L.1
Yan, Z.2
Liao, X.3
Li, Y.4
Yang, J.5
Wang, Z.G.6
Zuo, Y.7
Kawai, H.8
Shadfan, M.9
Ganapathy, S.10
-
20
-
-
0028118111
-
Tumor spectrum analysis in p53-mutant mice
-
Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA. 1994. Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1-7
-
(1994)
Curr Biol
, vol.4
, pp. 1-7
-
-
Jacks, T.1
Remington, L.2
Williams, B.O.3
Schmitt, E.M.4
Halachmi, S.5
Bronson, R.T.6
Weinberg, R.A.7
-
21
-
-
0028834902
-
Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53
-
Jones SN, Roe AE, Donehower LA, Bradley A. 1995. Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53. Nature 378: 206-208
-
(1995)
Nature
, vol.378
, pp. 206-208
-
-
Jones, S.N.1
Roe, A.E.2
Donehower, L.A.3
Bradley, A.4
-
22
-
-
0032417695
-
Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis
-
Jones SN, Hancock AR, Vogel H, Donehower LA, Bradley A. 1998. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc Natl Acad Sci 95: 15608-15612
-
(1998)
Proc Natl Acad Sci
, vol.95
, pp. 15608-15612
-
-
Jones, S.N.1
Hancock, A.R.2
Vogel, H.3
Donehower, L.A.4
Bradley, A.5
-
23
-
-
0027109075
-
Cancer. p53, guardian of the genome
-
Lane DP. 1992. Cancer. p53, guardian of the genome. Nature 358: 15-16
-
(1992)
Nature
, vol.358
, pp. 15-16
-
-
Lane, D.P.1
-
24
-
-
13644260907
-
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
-
Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM, Valentin-Vega YA, Terzian T, Caldwell LC, Strong LC, et al. 2004. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell 119: 861-872
-
(2004)
Cell
, vol.119
, pp. 861-872
-
-
Lang, G.A.1
Iwakuma, T.2
Suh, Y.A.3
Liu, G.4
Rao, V.A.5
Parant, J.M.6
Valentin-Vega, Y.A.7
Terzian, T.8
Caldwell, L.C.9
Strong, L.C.10
-
25
-
-
84884282500
-
Switching on p53: An essential role for protein phosphorylation?
-
Loughery J, Meek D. 2013. Switching on p53: An essential role for protein phosphorylation? BioDiscovery 8: 1
-
(2013)
BioDiscovery
, vol.8
, pp. 1
-
-
Loughery, J.1
Meek, D.2
-
26
-
-
0025633582
-
Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
-
Malkin D, Li FP, Strong LC, Fraumeni JF Jr, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ, Tainsky MA, et al. 1990. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 250: 1233-1238
-
(1990)
Science
, vol.250
, pp. 1233-1238
-
-
Malkin, D.1
Li, F.P.2
Strong, L.C.3
Fraumeni, J.F.4
Nelson, C.E.5
Kim, D.H.6
Kassel, J.7
Gryka, M.A.8
Bischoff, F.Z.9
Tainsky, M.A.10
-
27
-
-
0037220737
-
mdm2 is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation
-
Mendrysa SM, McElwee MK, Michalowski J, O'Leary KA, Young KM, Perry ME. 2003. mdm2 is critical for inhibition of p53 during lymphopoiesis and the response to ionizing irradiation. Mol Cell Biol 23: 462-472
-
(2003)
Mol Cell Biol
, vol.23
, pp. 462-472
-
-
Mendrysa, S.M.1
McElwee, M.K.2
Michalowski, J.3
O'Leary, K.A.4
Young, K.M.5
Perry, M.E.6
-
28
-
-
29944447632
-
Tumor suppression and normal aging in mice with constitutively high p53 activity
-
Mendrysa SM, O'Leary KA, McElwee MK, Michalowski J, Eisenman RN, Powell DA, Perry ME. 2006. Tumor suppression and normal aging in mice with constitutively high p53 activity. Genes Dev 20: 16-21
-
(2006)
Genes Dev
, vol.20
, pp. 16-21
-
-
Mendrysa, S.M.1
O'Leary, K.A.2
McElwee, M.K.3
Michalowski, J.4
Eisenman, R.N.5
Powell, D.A.6
Perry, M.E.7
-
29
-
-
0028823020
-
Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53
-
Montes de Oca Luna R,Wagner DS, Lozano G. 1995. Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature 378: 203-206
-
(1995)
Nature
, vol.378
, pp. 203-206
-
-
Montes de Oca Luna, R.1
Wagner, D.S.2
Lozano, G.3
-
30
-
-
10944236962
-
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
-
Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, Crowley D, Jacks T. 2004. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell 119: 847-860
-
(2004)
Cell
, vol.119
, pp. 847-860
-
-
Olive, K.P.1
Tuveson, D.A.2
Ruhe, Z.C.3
Yin, B.4
Willis, N.A.5
Bronson, R.T.6
Crowley, D.7
Jacks, T.8
-
31
-
-
84906084536
-
Limiting the power of p53 through the ubiquitin proteasome pathway
-
Pant V, Lozano G. 2014. Limiting the power of p53 through the ubiquitin proteasome pathway. Genes Dev 28: 1739-1751
-
(2014)
Genes Dev
, vol.28
, pp. 1739-1751
-
-
Pant, V.1
Lozano, G.2
-
32
-
-
79961039603
-
Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability
-
Pant V, Xiong S, Iwakuma T, Quintas-Cardama A, Lozano G. 2011. Heterodimerization of Mdm2 and Mdm4 is critical for regulating p53 activity during embryogenesis but dispensable for p53 and Mdm2 stability. Proc Natl Acad Sci 108: 11995-12000
-
(2011)
Proc Natl Acad Sci
, vol.108
, pp. 11995-12000
-
-
Pant, V.1
Xiong, S.2
Iwakuma, T.3
Quintas-Cardama, A.4
Lozano, G.5
-
33
-
-
84971595368
-
Distinct downstream targets manifest p53-dependent pathologies in mice
-
Pant V, Xiong S, Chau G, Tsai K, Shetty G, Lozano G. 2016. Distinct downstream targets manifest p53-dependent pathologies in mice. Oncogene doi: 10.1038/onc.2016. 111
-
(2016)
Oncogene
-
-
Pant, V.1
Xiong, S.2
Chau, G.3
Tsai, K.4
Shetty, G.5
Lozano, G.6
-
34
-
-
0034863683
-
Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53
-
Parant J, Chavez-Reyes A, Little NA, YanW, Reinke V, Jochemsen AG, Lozano G. 2001. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53. Nat Genet 29: 92-95
-
(2001)
Nat Genet
, vol.29
, pp. 92-95
-
-
Parant, J.1
Chavez-Reyes, A.2
Little, N.A.3
Yan, W.4
Reinke, V.5
Jochemsen, A.G.6
Lozano, G.7
-
35
-
-
84891937100
-
Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models
-
Perets R, Wyant GA, Muto KW, Bijron JG, Poole BB, Chin KT, Chen JY, Ohman AW, Stepule CD, Kwak S, et al. 2013. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer Cell 24: 751-765
-
(2013)
Cancer Cell
, vol.24
, pp. 751-765
-
-
Perets, R.1
Wyant, G.A.2
Muto, K.W.3
Bijron, J.G.4
Poole, B.B.5
Chin, K.T.6
Chen, J.Y.7
Ohman, A.W.8
Stepule, C.D.9
Kwak, S.10
-
36
-
-
77956510090
-
A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development
-
Post SM, Quintas-Cardama A, Pant V, Iwakuma T, Hamir A, Jackson JG, Maccio DR, Bond GL, Johnson DG, Levine AJ, et al. 2010. A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development. Cancer Cell 18: 220-230
-
(2010)
Cancer Cell
, vol.18
, pp. 220-230
-
-
Post, S.M.1
Quintas-Cardama, A.2
Pant, V.3
Iwakuma, T.4
Hamir, A.5
Jackson, J.G.6
Maccio, D.R.7
Bond, G.L.8
Johnson, D.G.9
Levine, A.J.10
-
37
-
-
82655181478
-
Multiple stress signals activate mutant p53 in vivo
-
Suh YA, Post SM, Elizondo-Fraire AC, Maccio DR, Jackson JG, El-Naggar AK, Van Pelt C, Terzian T, Lozano G. 2011. Multiple stress signals activate mutant p53 in vivo. Cancer Res 71: 7168-7175
-
(2011)
Cancer Res
, vol.71
, pp. 7168-7175
-
-
Suh, Y.A.1
Post, S.M.2
Elizondo-Fraire, A.C.3
Maccio, D.R.4
Jackson, J.G.5
El-Naggar, A.K.6
Van Pelt, C.7
Terzian, T.8
Lozano, G.9
-
38
-
-
34547192721
-
Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development
-
Terzian T,Wang Y, Van Pelt CS, Box NF, Travis EL, Lozano G. 2007. Haploinsufficiency of Mdm2 and Mdm4 in tumorigenesis and development. Mol Cell Biol 27: 5479-5485
-
(2007)
Mol Cell Biol
, vol.27
, pp. 5479-5485
-
-
Terzian, T.1
Wang, Y.2
Van Pelt, C.S.3
Box, N.F.4
Travis, E.L.5
Lozano, G.6
-
39
-
-
44149121239
-
The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
-
Terzian T, Suh YA, Iwakuma T, Post SM, Neumann M, Lang GA, Van Pelt CS, Lozano G. 2008. The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss. Genes Dev 22: 1337-1344
-
(2008)
Genes Dev
, vol.22
, pp. 1337-1344
-
-
Terzian, T.1
Suh, Y.A.2
Iwakuma, T.3
Post, S.M.4
Neumann, M.5
Lang, G.A.6
Van Pelt, C.S.7
Lozano, G.8
-
40
-
-
84905675480
-
Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage
-
Tollini LA, Jin A, Park J, Zhang Y. 2014. Regulation of p53 by Mdm2 E3 ligase function is dispensable in embryogenesis and development, but essential in response to DNA damage. Cancer Cell 26: 235-247
-
(2014)
Cancer Cell
, vol.26
, pp. 235-247
-
-
Tollini, L.A.1
Jin, A.2
Park, J.3
Zhang, Y.4
-
41
-
-
85018743075
-
Targeting the MDM2-p53 protein-protein interaction for new cancer therapy: Progress and challenges
-
Wang S, Zhao Y, Aguilar A, Bernard D, Yang C. 2016. Targeting the MDM2-p53 protein-protein interaction for new cancer therapy: Progress and challenges. Cold Spring Harb Perspect Med 6: a 026245
-
(2016)
Cold Spring Harb Perspect Med
, vol.6
-
-
Wang, S.1
Zhao, Y.2
Aguilar, A.3
Bernard, D.4
Yang, C.5
-
42
-
-
84982786849
-
Attenuating the p53 pathway in human cancers: Many means to the same end
-
Wasylishen AR, Lozano G. 2016. Attenuating the p53 pathway in human cancers: Many means to the same end. Cold Spring Harb Perspect Med 6: a 026211
-
(2016)
Cold Spring Harb Perspect Med
, vol.6
-
-
Wasylishen, A.R.1
Lozano, G.2
-
43
-
-
33644757727
-
Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development
-
Xiong S, Van Pelt CS, Elizondo-Fraire AC, Liu G, Lozano G. 2006. Synergistic roles of Mdm2 and Mdm4 for p53 inhibition in central nervous system development. Proc Natl Acad Sci 103: 3226-3231
-
(2006)
Proc Natl Acad Sci
, vol.103
, pp. 3226-3231
-
-
Xiong, S.1
Van Pelt, C.S.2
Elizondo-Fraire, A.C.3
Liu, G.4
Lozano, G.5
-
44
-
-
77956926019
-
Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4
-
Xiong S, Pant V, Suh YA, Van Pelt CS,Wang Y, Valentin-Vega YA, Post SM, Lozano G. 2010. Spontaneous tumorigenesis in mice overexpressing the p53-negative regulator Mdm4. Cancer Res 70: 7148-7154
-
(2010)
Cancer Res
, vol.70
, pp. 7148-7154
-
-
Xiong, S.1
Pant, V.2
Suh, Y.A.3
Van Pelt, C.S.4
Wang, Y.5
Valentin-Vega, Y.A.6
Post, S.M.7
Lozano, G.8
-
45
-
-
84885651314
-
A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection
-
Zeron-Medina J, Wang X, Repapi E, Campbell MR, Su D, Castro-Giner F, Davies B, Peterse EF, Sacilotto N, Walker GJ, et al. 2013. A polymorphic p53 response element in KIT ligand influences cancer risk and has undergone natural selection. Cell 155: 410-422
-
(2013)
Cell
, vol.155
, pp. 410-422
-
-
Zeron-Medina, J.1
Wang, X.2
Repapi, E.3
Campbell, M.R.4
Su, D.5
Castro-Giner, F.6
Davies, B.7
Peterse, E.F.8
Sacilotto, N.9
Walker, G.J.10
-
46
-
-
84904267177
-
Tissue-specific and agedependent effects of global Mdm2 loss
-
Zhang Y, Xiong S, Li Q, Hu S, Tashakori M, Van Pelt C, You MJ, Pageon L, Lozano G. 2014. Tissue-specific and agedependent effects of global Mdm2 loss. J Pathol 233: 380-391
-
(2014)
J Pathol
, vol.233
, pp. 380-391
-
-
Zhang, Y.1
Xiong, S.2
Li, Q.3
Hu, S.4
Tashakori, M.5
Van Pelt, C.6
You, M.J.7
Pageon, L.8
Lozano, G.9
|